SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-066521
Filing Date
2022-05-31
Accepted
2022-05-31 16:01:13
Documents
12
Period of Report
2022-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2217146d1_8k.htm   iXBRL 8-K 24616
  Complete submission text file 0001104659-22-066521.txt   195428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gild-20220525.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20220525_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20220525_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2217146d1_8k_htm.xml XML 3488
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 22983105
SIC: 2836 Biological Products, (No Diagnostic Substances)